MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0001406
Oncare Pharmaceuticals Private Limited - trading in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹59.68 Lakh
▲ 33% YoY
Net profit · FY 2024
₹42,458
Net margin 0.7%
EBITDA · FY 2024
₹3.66 Lakh
EBITDA margin 6.1%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹22 Lakh
Satisfied ₹4.5 Lakh
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Oncare Pharmaceuticals Private Limited
Data last updated:
Oncare Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 26 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2010PTC032430. Its GSTIN is 04AABCO3420C1Z9 (Chandigarh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Ribhav Sharma and Rajesh Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 178 Sector 35 – D, Chandigarh, India – 160035.
As per the financials filed for FY 2024, the company reported a revenue of ₹59.68 Lakh, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹42,458 (net margin 0.7%) and EBITDA of ₹3.66 Lakh (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹22 Lakh and satisfied charges of ₹4.5 Lakh on record.
Oncare Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0001406). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oncare.in.
Company details
CIN U24232CH2010PTC032430
Registration Number 032430
Incorporation Date 26 August 2010
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0001406
Recognitions & Rankings of Oncare Pharmaceuticals
Contact details
Oncare Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its website is oncare.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No. 178 Sector 35 – D, Chandigarh, India – 160035
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Oncare Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Oncare Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Oncare Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Oncare Pharmaceuticals Private Limited, buy the company report.
Financials of Oncare Pharmaceuticals Private Limited
FY 2025 filings availableOncare Pharmaceuticals Private Limited reported revenue of ₹59.68 Lakh (up 33% YoY) for FY 2024.
Revenue · FY 2024
₹59.68 Lakh ▲ 33%
Net profit · FY 2024
₹42,458 margin 0.7%
EBITDA · FY 2024
₹3.66 Lakh margin 6.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 8%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 33% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42,458 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oncare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oncare Pharmaceuticals Private Limited
Oncare Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ribhav Sharma | Director | 23 Dec 2022 | 3 Years 10 Months | Current |
| Rajesh Kumar Sharma | Director | 26 Aug 2010 | 16 Years 2 Months | Current |
Peer comparison
Oncare Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brown Brunel Pharmaceuticals (OPC) Private Limited | ₹59.68 Lakh (FY 2021) | 481.0% | Anjuna, Goa, India | |||
| Oncare Pharmaceuticals Private Limitedthis company | ₹59.68 Lakh (FY 2024) | ₹42,458 | 0.7% | 33.0% | Chandigarh, India | |
| Apindex Pharmaceuticals Private Limited | ₹59.49 Lakh (FY 2025) | 6.0% | Surat, Gujarat, India | |||
| Arcutis Pharmaceuticals Private Limited | ₹59.4 Lakh (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Capskii Pharmaceuticals Private Limited | ₹58.97 Lakh (FY 2025) | -2.0% | Delhi, India |
To see the full peer comparison of Oncare Pharmaceuticals Private Limited, buy the company report.
Auditor
Oncare Pharmaceuticals Private Limited is audited by Grover Dinesh & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Grover Dinesh & Associates | FY 2017 | 012455N |
Shareholding
The shareholding of Oncare Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Oncare Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹22 Lakh
Satisfied charges
₹4.5 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Jul 2016 | 100043594 | Others | ₹7 Lakh | Open | |
| 17 Jan 2012 | 10333597 | Others | ₹15 Lakh | Open | |
| 26 Mar 2012 | 10347895 | Punjab National Bank | ₹4.5 Lakh | Satisfied |
To see the full charge records of Oncare Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Oncare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oncare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oncare Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AABCO3420C1Z9 | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Oncare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oncare Pharmaceuticals Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Ribhav Sharma was appointed as Director on 23 Dec 2022.
AGM
Oncare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Oncare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Ribhav Sharma was appointed as Director.
Ceased
Rameshwar Das Sharma ceased to be Director.
Charges
A charge registered on 26 Mar 2012 via Charge ID 10347895 with Punjab National Bank was fully satisfied on 05 Sep 2016.
Charges
A charge with Others of Rs. 15.00 Lakh registered on 17 Jan 2012 with Charge ID 10333597 was modified on 17 Aug 2016.
Charges
A charge with Others amounted to Rs. 7.00 Lakh with Charge ID 100043594 was registered on 15 Jul 2016.
Ceased
Mohit Goyal ceased to be Director.
Charges
A charge with Punjab National Bank amounted to Rs. 4.50 Lakh with Charge ID 10347895 was registered on 26 Mar 2012.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 10333597 was registered on 17 Jan 2012.
Appointed
Rajesh Kumar Sharma was appointed as Director.
Incorporation
26 Aug 2010
Oncare Pharmaceuticals Private Limited was registered on 26 Aug 2010 with Roc Chandigarh & aged 16 years 2 months as per MCA records.
Frequently asked questions
Oncare Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in retail trading, within the trading industry. It was incorporated on 26 August 2010 (16+ years old) and is registered under CIN U24232CH2010PTC032430.
Oncare Pharmaceuticals has 2 current directors:
- Ribhav Sharma - Director
- Rajesh Kumar Sharma - Director
The latest financial statements of Oncare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Oncare Pharmaceuticals is 04AABCO3420C1Z9, registered in Chandigarh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Oncare Pharmaceuticals is U24232CH2010PTC032430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oncare Pharmaceuticals was incorporated on 26 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Oncare Pharmaceuticals by revenue are Brown Brunel Pharmaceuticals (OPC) Private Limited, Apindex Pharmaceuticals Private Limited, Arcutis Pharmaceuticals Private Limited, Capskii Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ribhav Sharma was appointed as Director on 23 Dec 2022. Rameshwar Das Sharma ceased to be Director on 01 Dec 2022. Mohit Goyal ceased to be Director on 09 Apr 2013. Oncare Pharmaceuticals has 4 board changes on record in total.
Yes, Oncare Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0001406).
Oncare Pharmaceuticals can be reached through the website oncare.in. Its registered office is in Chandigarh, India.
The registered office of Oncare Pharmaceuticals is at Shop No. 178 Sector 35 – D, Chandigarh, India – 160035.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages